Federal Register Notice: FDA’s collection of information entitled “Waivers of In Vivo Demonstration of Bioequivalence of Animal Drugs in Soluble Powder Oral Dosage Form and Type A Medicated Articles,” has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. To view this notice, click here.
